Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05HNO
|
||||
| Former ID |
DNC008680
|
||||
| Drug Name |
3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530576] | ||
| Structure |
|
Download |
|||
| Formula |
C20H22N2O3
|
||||
| Canonical SMILES |
C1CCC(CC1)NC(=O)OC2=CC=CC(=C2)C3=CC(=CC=C3)C(=O)N
|
||||
| InChI |
1S/C20H22N2O3/c21-19(23)16-8-4-6-14(12-16)15-7-5-11-18(13-15)25-20(24)22-17-9-2-1-3-10-17/h4-8,11-13,17H,1-3,9-10H2,(H2,21,23)(H,22,24)
|
||||
| InChIKey |
ROFVXGGUISEHAM-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530576] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||